Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
128 participants
INTERVENTIONAL
2025-09-01
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will get one of two procedures. One is called injection laryngoplasty (IL) and injects a gel into the back wall of the participant's airway to prevent food and liquid from falling in. The other procedure is called endoscopic suture repair (ER) and uses sutures to sew together and build up the back wall of the participant's airway to prevent food and liquid from falling in. Participants will be asked to have a number of tests and procedures. These include a modified barium swallow study, in which the participant drinks and eats foods and liquids with barium in them and X-rays are used to assess how the food moves through the participant's body. This will be done before the procedure and 3 months after the procedure. The investigators will also give participants questionnaires to complete before and after the procedure.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures
NCT06579989
Influence of Modified Diet, Exercise and Electrical Swallowing Muscle Stimulation on Swallowing Function and Quality of Life in Elderly Patients With Oropharyngeal Dysphagia
NCT05325658
Voice and Swallow Outcomes After Office-based Injection Laryngoplasty in Patients With Glottal Insufficiency
NCT06161064
Laryngeal Reinnervation Versus Thyroplasty in Patients With Vocal Fold Weakness.
NCT02973152
Treatment of Dysphagia by Using a Synchronized Electrical Stimulation Device
NCT02718963
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Group 1 will get IL for this condition.
* Group 2 will get ER for this condition
A computer will assign each participant to a group in no particular order. This is called randomization. Half of participants in this study will get IL. Half of participants will get ER. Each participant will have an equal chance of being in either group.
Neither the participants, the study doctor(s), nor the speech pathologist will know whether each participant will get the IL or ER. Only the surgeon will know which treatment the participant gets. The study is done this way because knowing which method the participant receives can change the results of the study.
If participants experience any serious side effects, the study doctor can find out which method they received so that any side effects can be treated properly.
Participants will need to have the following tests to find out if they can be in the study:
* Physical exam
* Demographic information/medical history
* Video fluoroscopic swallow study (VFSS) - X-ray videos that allow investigators to watch how food and liquids go down as a participant swallows them
If participant's screening tests show that they can take part in the study and they choose to be part of the study, they will also have to do the following tests:
* VFSS 3 months after the procedure
* Questionnaires asking about the emotional and physical burden of participant's swallowing issues, both before and after the procedure
* Overnight monitoring in the hospital after the procedure
* Follow up in clinic for up to 2 years after the procedure
Participant's medical records may be reviewed. Information reviewed may include treatment history, medications, surgeries, allergies, scans, and lab results.
Once participant's participation in the study ends, their medical provider(s) will help them choose the next step in their care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endoscopic suture repair
Children receiving endoscopic suture repair of laryngeal cleft
Endoscopic suture repair
Children receiving endoscopic suture repair of laryngeal cleft
Injection laryngoplasty
Children receiving injection of the interarytenoid space of laryngeal cleft
Injection laryngoplasty
Children receiving injection of the interarytenoid space for laryngeal cleft treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic suture repair
Children receiving endoscopic suture repair of laryngeal cleft
Injection laryngoplasty
Children receiving injection of the interarytenoid space for laryngeal cleft treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Down syndrome
* Prematurity \< 28 weeks gestational age
* Hypoxic brain injury
* Any syndrome with significant hypotonia
* History of nothing by mouth (NPO) for \> 1 month prior to assessment
* \>50% of nutrition by G-tube
* Tracheostomy
* History of prior IL or ER
12 Months
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Derek Lam, MD, MPH
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Science University
Portland, Oregon, United States
Vanderbilt University
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00027965
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.